Comparison between use sublingual misoprostol and blood loss during myomectomy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2014071414621N1

Enrollment

Registered

2014-07-20

Start date

2013-08-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uterine myoma. Other specified noninflammatory disorders of uterus

Interventions

Intervention 1: In treatment group 200 micrograms sub lingual misoprostol 1 hour before surgery. Intervention 2: In control group placebo.

Treatment - Drugs

Placebo

In treatment group 200 micrograms sub lingual misoprostol 1 hour before surgery

In control group placebo

Eligibility

Sex/Gender

Female

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Over 18 years old; anemia due to Abnormal uterine bleeding;uterine myoma under 8cm in sonography. Exclusion criteria: known bleeding disease; active asthma; high diastolic blood pressure; recent NSAIDS use; known hepatic disease; severe anemia; allergy and recent received packed cell .

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Bleeding. Timepoint: Preoparation,6 & 24& 48 hours after surgery. Method of measurement: Check of hemoglobin(CBC).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Sara Asadollah

Iran University of Medical Sciences

m-vahdat@sina.tums.ac.ir,sara_asadolla@yahoo.com+98 21 6651 6001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026